{"cdcTestId":"2013-0606","testcaseName":"Dose 1 to dose 2 interval 28-4 days","vaccineGroup":"PCV","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-25T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2023-01-25T00:00:00","pastDueDate":"2023-03-24T00:00:00"},"doses":[{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T07:39:35.912","generalDescription":"This test case describes when dose #1 and dose #2 of the Pnuemococal 13 vaccine is administered at  28 - 4 days that the second dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}